8DXU
Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2022-06-11 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.9537 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 55.235, 102.085, 201.821 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.547 - 2.728 |
R-factor | 0.2251 |
Rwork | 0.223 |
R-free | 0.26900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | generic fab and SARS-CoV-2 RBD |
RMSD bond length | 0.003 |
RMSD bond angle | 0.706 |
Data reduction software | XDS |
Data scaling software | Aimless (0.7.7) |
Phasing software | PHASER (2.8.3) |
Refinement software | PHENIX (1.11.1-2575) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 49.480 | 49.480 | 2.860 |
High resolution limit [Å] | 2.728 | 9.050 | 2.730 |
Rmerge | 0.156 | 0.049 | 1.384 |
Rmeas | 0.163 | 0.052 | 1.459 |
Rpim | 0.047 | 0.015 | 0.455 |
Total number of observations | 11627 | 39714 | |
Number of reflections | 31192 | 979 | 3918 |
<I/σ(I)> | 12.8 | 42.6 | 1.7 |
Completeness [%] | 99.4 | 99.6 | 95.8 |
Redundancy | 11.9 | 11.9 | 10.1 |
CC(1/2) | 0.998 | 0.999 | 0.672 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6 | 293 | Two uL of protein solution (~5 mg/mL of 1:1:1 complex in 25 mM Tris (pH 8.0), 200 mM NaCl) was combined with an equal volume of well solution (100 mM MMT buffer system (Molecular Dimensions) (pH 6.0), 19% (w/v) PEG6000. |